Menu Search
Equities

Akzo Nobel NV

AKU:BRN

Akzo Nobel NV

Actions
  • Price (CHF)60.27
  • Today's Change0.00 / 0.00%
  • Shares traded140.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 17 2020.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Akzo Nobel NV had relatively flat revenues (10.85bn to 10.67bn), though the company grew net income 25.57% from 352.00m to 442.00m. A reduction in the cost of goods sold as a percentage of sales from 63.83% to 60.31% was a component in the net income growth despite flat revenues.
Gross margin40.82%
Net profit margin5.72%
Operating margin9.02%
Return on assets4.00%
Return on equity12.60%
Return on investment6.59%
More ▼

Cash flow in EURView more

In 2023, Akzo Nobel NV did not generate a significant amount of cash. However, the company earned 1.12bn from its operations for a Cash Flow Margin of 10.50%. In addition the company used 144.00m on investing activities and also paid 827.00m in financing cash flows.
Cash flow per share5.70
Price/Cash flow per share9.86
Book value per share26.80
Tangible book value per share3.32
More ▼

Balance sheet in EURView more

Akzo Nobel NV has a Debt to Total Capital ratio of 56.51%, a lower figure than the previous year's 83.44%.
Current ratio1.21
Quick ratio0.8947
Total debt/total equity1.37
Total debt/total capital0.5651
More ▼

Growth rates in EUR

SmartText is unavailable
Div yield(5 year avg)2.02%
Div growth rate (5 year)1.41%
Payout ratio (TTM)50.83%
EPS growth(5 years)8.21
EPS (TTM) vs
TTM 1 year ago		37.25
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.